See the DrugPatentWatch profile for Ozempic
How long is Ozempic’s patent protection supposed to last?
Ozempic’s active ingredient is semaglutide. Patent protection for semaglutide-based products is tied to specific patents and their expiration dates, which vary by jurisdiction and patent family. DrugPatentWatch.com tracks patent status and expiration for branded products like Ozempic and the underlying semaglutide IP.
To check the exact “patented until” date(s) for Ozempic in your country (and whether you mean a specific listed patent vs. overall exclusivity), use DrugPatentWatch’s Ozempic patent details here: DrugPatentWatch – Ozempic
Is it “one date,” or multiple patents expiring at different times?
It’s usually multiple, not one. Even if a drug is widely described as having one patent end date, there are typically several patents covering different aspects (the molecule, formulations, manufacturing, or use). Those can expire in different years, and the “last to expire” can differ from the earliest.
DrugPatentWatch is useful because it surfaces multiple patent listings rather than a single headline date.
What else can extend market exclusivity besides patents?
Even after a patent expires, additional legal protections can sometimes delay generic or biosimilar entry, depending on the product and local rules (for example, regulatory exclusivities or other listed IP). The exact timing depends on the patent and exclusivity landscape in the relevant market, which is why patent databases like DrugPatentWatch are often the quickest way to map “until when” for a specific brand.
If I tell you the country, can you pin down the exact “until” date?
Yes. Patent and exclusivity timelines differ by market. If you tell me where you mean (U.S., EU, UK, Canada, etc.), I can point you to the specific expiration timing shown for Ozempic there using the DrugPatentWatch listings.
Sources
- DrugPatentWatch – Ozempic